Announcements Trials
Browse Landscape

Phase

Phase 1 14Phase 2 12Phase NA 11Phase 3 6Phase 4 5Phase EARLY_PHASE1 2

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 5OTHER 3OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Plasma cell 2Genitourinary 1Breast 1

Conditions

Neoplasms 66Breast Neoplasms 64Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 40Neoplasm Metastasis 23Colorectal Neoplasms 21Multiple Myeloma 20Pain 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Anemia 16Keratosis, Actinic 15Lung Neoplasms 14Cancer Pain 14Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 11Leukemia 11Leukemia, Lymphocytic, Chronic, B-Cell 10Carcinoma, Renal Cell 10Carcinoma, Hepatocellular 9Carcinoma 9Neuroendocrine Tumors 8Melanoma 8Lymphoma 8Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Uterine Cervical Neoplasms 6Recurrence 6Gastrointestinal Stromal Tumors 6Stomatitis 5Stomach Neoplasms 5

Interventions

Ibandronic Acid 2Zoledronic Acid 1Pregabalin 1Kyphoplasty 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Bone Neoplasms × Clear all
NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated
152 enrolled 14 charts
Sarcoma

Bone Neoplasms, Neoplasms, Pain, Intractable

NCT00211211 2017-12-08

FREE Study - Fracture Reduction Evaluation

Medtronic Spinal and Biologics

Phase 4 Completed
300 enrolled
Plasma cellSarcoma

Back Pain, Bone Diseases, Metabolic, Bone Neoplasms, Multiple Myeloma, Osteoporosis

NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

NCT02564107 2016-11-02

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Hoffmann-La Roche

Phase 4 Completed
48 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT02553707 2015-09-17

A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer

Hoffmann-La Roche

Phase 4 Completed
182 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡